StockData
IM Cannabis Corp. logo

IM Cannabis Corp. (IMCC) KPIs and segments

IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026Score 4/30
$0.55−0.02 (-3.83%)

Close on Nov 12, 2026Market cap $3.26MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive IM Cannabis's business

IM Cannabis's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q2 2024
Q2 2023
Q2 2022
Germany(C$M)
0.67-0.21-0.98
Adjustments(C$M)
00-1.12
Israel(C$M)
-2.82-0.23-3.52
Earlier reporting (last reported 2023)3

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-03-30.

See a number that looks wrong?